Secondary |
Cardiac Failure |
15.2% |
Insomnia |
14.1% |
Pain |
8.1% |
Product Used For Unknown Indication |
8.1% |
Conjunctivitis Allergic |
6.1% |
Constipation |
6.1% |
Thrombosis Prophylaxis |
6.1% |
Withdrawal Syndrome |
6.1% |
Drug Use For Unknown Indication |
5.1% |
Atrial Fibrillation |
3.0% |
Back Pain |
3.0% |
Cardiac Failure Chronic |
3.0% |
Gastritis Prophylaxis |
3.0% |
Hyperuricaemia |
3.0% |
Dementia With Lewy Bodies |
2.0% |
Dyslipidaemia |
2.0% |
Hypertension |
2.0% |
Prophylaxis |
2.0% |
Dementia Alzheimer's Type |
1.0% |
Hyperlipidaemia |
1.0% |
|
Cerebral Infarction |
33.3% |
Eyelid Ptosis |
22.2% |
Drug Prescribing Error |
11.1% |
Intentional Overdose |
11.1% |
Pancreatitis Acute |
11.1% |
Withdrawal Syndrome |
11.1% |
|
Concomitant |
Prophylaxis |
18.5% |
Insomnia |
11.2% |
Drug Use For Unknown Indication |
7.9% |
Multiple Myeloma |
7.4% |
Pain |
7.3% |
Hepatitis C |
7.3% |
Product Used For Unknown Indication |
7.0% |
Hypertension |
6.0% |
Constipation |
4.9% |
Chronic Hepatitis C |
3.3% |
Gastritis |
2.9% |
Rheumatoid Arthritis |
2.6% |
Pustular Psoriasis |
2.2% |
Diabetes Mellitus |
1.9% |
Angina Pectoris |
1.7% |
Cancer Pain |
1.7% |
Ovarian Cancer Recurrent |
1.7% |
Hyperlipidaemia |
1.5% |
Metastatic Renal Cell Carcinoma |
1.5% |
Stomatitis |
1.5% |
|
White Blood Cell Count Decreased |
14.4% |
Vomiting |
8.0% |
Renal Impairment |
6.9% |
Interstitial Lung Disease |
5.9% |
Pneumonia |
5.9% |
Rash |
5.9% |
Dizziness |
4.8% |
Hepatic Function Abnormal |
4.3% |
Liver Disorder |
4.3% |
Platelet Count Decreased |
4.3% |
Pyrexia |
4.3% |
Upper Respiratory Tract Inflammation |
4.3% |
Decreased Appetite |
3.7% |
Hyponatraemia |
3.7% |
Lung Disorder |
3.7% |
Febrile Neutropenia |
3.2% |
Haemoglobin Decreased |
3.2% |
Hyperuricaemia |
3.2% |
Renal Cell Carcinoma |
3.2% |
Sepsis |
3.2% |
|
Interacting |
Epilepsy |
75.0% |
Insomnia |
25.0% |
|
Blood Amylase Increased |
50.0% |
Weight Decreased |
50.0% |
|